Alphabet
Latest statistics and disclosures from Alphabet's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPCX, PL, ASTS, CME, ARM, and represent 98.51% of Alphabet's stock portfolio.
- Added to shares of these 3 stocks: SPCX (+$94B), Parabilis Medicines (+$135M), Fervo Energy (+$52M).
- Started 3 new stock positions in SPCX, Fervo Energy, Parabilis Medicines.
- Reduced shares in these 5 stocks: RVMD (-$65M), GLUE (-$7.5M), RLAY, LIFE, TNYA.
- Sold out of its position in TNYA.
- Alphabet was a net buyer of stock by $94B.
- Alphabet has $99B in assets under management (AUM), dropping by 2367.45%.
- Central Index Key (CIK): 0001652044
Tip: Access up to 7 years of quarterly data
Positions held by Alphabet consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Alphabet
Alphabet holds 28 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Space Exploration Techn Corp Class A Com Stk (SPCX) | 95.0 | $94B | NEW | 551M | 170.86 |
|
| Planet Labs Pbc Com Cl A (PL) | 1.2 | $1.2B | 35M | 33.13 |
|
|
| Ast Spacemobile Com Cl A (ASTS) | 0.8 | $795M | 8.9M | 88.86 |
|
|
| Cme (CME) | 0.8 | $769M | 3.5M | 220.83 |
|
|
| Arm Holdings Sponsored Ads (ARM) | 0.7 | $695M | 2.0M | 354.57 |
|
|
| Revolution Medicines (RVMD) | 0.6 | $552M | -10% | 2.9M | 187.28 |
|
| Freshworks Class A Com (FRSH) | 0.2 | $164M | 16M | 10.12 |
|
|
| Parabilis Medicines | 0.1 | $135M | NEW | 4.9M | 27.37 |
|
| Tempus Ai Cl A (TEM) | 0.1 | $90M | 1.6M | 57.93 |
|
|
| Gitlab Class A Com (GTLB) | 0.1 | $83M | 2.7M | 30.53 |
|
|
| Uipath Cl A (PATH) | 0.1 | $77M | 7.0M | 10.87 |
|
|
| Ethos Technologies Cl A (LIFE) | 0.1 | $66M | -3% | 3.6M | 18.14 |
|
| Prime Medicine (PRME) | 0.1 | $61M | 17M | 3.69 |
|
|
| Fervo Energy Cl A Com | 0.1 | $52M | NEW | 1.8M | 29.23 |
|
| Paypay Corp Sponsored Ads (PAYP) | 0.0 | $45M | 3.1M | 14.33 |
|
|
| Maze Therapeatics (MAZE) | 0.0 | $41M | 1.4M | 29.84 |
|
|
| Relay Therapeutics (RLAY) | 0.0 | $26M | -9% | 1.4M | 18.71 |
|
| Bridgebio Oncology Therapeut Com New (BBOT) | 0.0 | $22M | 2.8M | 7.62 |
|
|
| Oscar Health Cl A (OSCR) | 0.0 | $14M | 482k | 28.52 |
|
|
| Beam Therapeutics (BEAM) | 0.0 | $11M | 322k | 34.32 |
|
|
| Vera Therapeutics Cl A (VERA) | 0.0 | $10M | 241k | 42.91 |
|
|
| Sana Biotechnology (SANA) | 0.0 | $9.8M | 2.8M | 3.49 |
|
|
| Monte Rosa Therapeutics (GLUE) | 0.0 | $9.0M | -45% | 373k | 24.20 |
|
| Lyell Immunopharma Com New (LYEL) | 0.0 | $4.1M | 293k | 14.05 |
|
|
| Figma Class A Com Stk (FIG) | 0.0 | $3.9M | 216k | 18.09 |
|
|
| Spero Therapeutics (SPRO) | 0.0 | $2.0M | 890k | 2.21 |
|
|
| Hyperfine Com Cl A (HYPR) | 0.0 | $1.2M | 899k | 1.35 |
|
|
| Autolus Therapeutics Spon Ads (AUTL) | 0.0 | $1.1M | 698k | 1.60 |
|
Past Filings by Alphabet
SEC 13F filings are viewable for Alphabet going back to 2022
- Alphabet 2026 Q2 filed Aug. 7, 2026
- Alphabet 2026 Q1 filed May 8, 2026
- Alphabet 2025 Q4 filed Feb. 13, 2026
- Alphabet 2025 Q3 filed Nov. 7, 2025
- Alphabet 2025 Q2 filed Aug. 1, 2025
- Alphabet 2025 Q1 filed May 2, 2025
- Alphabet 2024 Q4 filed Feb. 7, 2025
- Alphabet 2024 Q3 filed Nov. 8, 2024
- Alphabet 2024 Q2 filed Aug. 2, 2024
- Alphabet 2024 Q1 filed May 3, 2024
- Alphabet 2023 Q4 filed Feb. 9, 2024
- Alphabet 2023 Q3 filed Nov. 13, 2023
- Alphabet 2023 Q2 filed Aug. 4, 2023
- Alphabet 2023 Q1 filed May 11, 2023
- Alphabet 2022 Q4 filed Feb. 14, 2023
- Alphabet 2022 Q3 filed Nov. 15, 2022